Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Tdf Ftc'

Tdf Ftc published presentations and documents on DocSlides.

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

EFFECTS ON RENAL FUNCTION OF A SWITCH FROM TENOFOVIR (TDF)

  • tawny-fly
  • 20 Slides

M Harris, . S Guillemi. , K Chan, B Yip. ,. . M ...

Switch from TDF to TAF

Switch from TDF to TAF

  • easyho
  • 13 Slides

GS-US-292-0109 Study. GS-US-311-1089 Study. . De...

Switch to DOR-TDF-3TC vs. Continued Baseline Regimen

Switch to DOR-TDF-3TC vs. Continued Baseline Regimen

  • dorothy
  • 8 Slides

DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...

Switch

Switch

  • lindy-dunigan
  • 13 Slides

from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...

1 Adam O’Neill Leonid

1 Adam O’Neill Leonid

  • celsa-spraggs
  • 137 Slides

Reyzin. Boston University. . A Unified Approach ...

Comparison of NRTI combinations

Comparison of NRTI combinations

  • tawny-fly
  • 20 Slides

ZDV/3TC . vs. TDF + FTC. Study 934. ABC/3TC . vs...

HBV resistance and

HBV resistance and

  • calandra-battersby
  • 21 Slides

immune escape . mutants. Anders Boyd, MPH, . PhD....

Switch to DRV/r + RAL

Switch to DRV/r + RAL

  • debby-jeon
  • 5 Slides

SPARE . Study. SPARE Study: switch to DRV/r + RAL...

ID Week Review 2015

ID Week Review 2015

  • briana-ranney
  • 17 Slides

Brian R. Wood, MD. Assistant Professor of Medicin...

Tyre Stewardship in Canada

Tyre Stewardship in Canada

  • sherrill-nordquist
  • 0 Slides

Presented to . New Zealand . Tyre. Industry Summ...

Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-

Comparative effectiveness of first-line antiretroviral therapy regimens: results from a large real-

  • min-jolicoeur
  • 0 Slides

implementation of Dolutegravir. Meireles MV. , Pa...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Common Pharmacomistakes in Advanced Illness

Common Pharmacomistakes in Advanced Illness

  • tawny-fly
  • 42 Slides

Common Pharmacomistakes in Advanced Illness Opioi...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Evolving Options for HBV Therapy:

Evolving Options for HBV Therapy:

  • desiron
  • 39 Slides

Navigating the New Treatment Landscape. Outline. I...

Phase 2 of new ARVs Fostemsavir

Phase 2 of new ARVs Fostemsavir

  • sportyinds
  • 10 Slides

, . prodrug. of . temsavir. . (. attachment inhi...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

  • sistertive
  • 31 Slides

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

Target Date Funds and P

Target Date Funds and P

  • unita
  • 12 Slides

lan . S. ponsor Responsibilities. Marcia S. Wagner...

Brad Hare Nothing to Disclose

Brad Hare Nothing to Disclose

  • beatrice
  • 17 Slides

Kaiser Permanente San Francisco Medical Center. Sa...

Renal and Bone Safety of

Renal and Bone Safety of

  • ashley
  • 16 Slides

Tenofovir. . Alafenamide. . vs. . Tenofovir. ....

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

Total Soluble and Insoluble Dietary Fibre Contents of Wild Growing E

  • alyssa
  • 7 Slides

302 Vol. 32, 2014, No. 3: 302–307Czech J. Fo...

Retirement Plan Consulting

Retirement Plan Consulting

  • oconnor
  • 30 Slides

Overview of Services. Table of Contents. About RPA...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

  • micah
  • 16 Slides

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

Raltegravir plus Ritonavir-Boosted Darunavir NEAT001/ANRS 143 Trial

  • matthew167
  • 11 Slides

NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir ...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Update on risk factors, detection, and management of neuroc

Update on risk factors, detection, and management of neuroc

  • natalia-silvester
  • 61 Slides

Scott Letendre, M.D.. Professor of . Medicine and...

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

CDC’s Interim Guidance on the Use of PrEP in Heterosexual

  • calandra-battersby
  • 81 Slides

Adults:. . Implications . for Clinical Practice....

COMING SOON:

COMING SOON:

  • luanne-stotts
  • 31 Slides

GENERIC ARVs. Tim Horn. Treatment Action Group. t...

TDF Microsoft Lync - Novembre 2010

TDF Microsoft Lync - Novembre 2010

  • faustina-dinatale
  • 9 Slides

Solutions & Architectures UC . Polycom. - Mi...

Highlights of AIDS

Highlights of AIDS

  • calandra-battersby
  • 44 Slides

2016: Advances in . HIV Prevention, Care and Trea...

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

COMPARATIVE INVESTIGATIONS ON NUTRITIONAL COMPOSITIONS OF O

  • lois-ondreau
  • 55 Slides

GROWN CEREALS AND THEIR RELATIONSHIPS. Dr. . Mirj...

Switch to PI/r + 3TC

Switch to PI/r + 3TC

  • lois-ondreau
  • 6 Slides

vs. PI/r . monotherapy. Study PIVOT. Study MOBID...

A Demonstration Open Label

A Demonstration Open Label

  • jane-oiler
  • 0 Slides

Study to Assess the . Acceptability. , Safety. a...

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

  • calandra-battersby
  • 0 Slides

Learning Objectives. Understand when to switch to...

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine

  • luanne-stotts
  • 0 Slides

Chief, Division of Infectious Diseases. Weill Med...

ART in Resource-limited settings :

ART in Resource-limited settings :

  • liane-varnes
  • 0 Slides

Progress and Challenges. Dr. B. B. . Rewari. MD,...

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient

  • min-jolicoeur
  • 0 Slides

Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

  • pamella-moone
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents i...

Duke Energy Carolinas ATC Calculation Process

Duke Energy Carolinas ATC Calculation Process

  • stefany-barnette
  • 0 Slides

ATC Training. December 15. th. , 2011. Agenda. Ob...

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

  • conchita-marotz
  • 0 Slides

A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...

Copyright © 2025 DocSlides. All Rights Reserved